Orthosteric Ligand Design Services

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Every degrader program starts with one practical question: can a small molecule be placed into the target protein in a way that survives linker attachment, keeps target recognition intact, and still allows a productive ternary complex to assemble? For orthosteric sites, the answer depends on how well the warhead fits the natural ligand pocket and how intelligently its exit vector is engineered. BOC Sciences provides dedicated orthosteric warhead design services for PROTAC and molecular glue programs, combining structural analysis, computational modeling, medicinal chemistry, and biophysical validation to convert known inhibitors, screening hits, and novel chemotypes into degradation-ready target-binding modules.

Request a Consultation Explore Services
Overview

What Is an Orthosteric Warhead in Targeted Protein Degradation?

An orthosteric warhead is the target-binding module of a degrader that occupies the same pocket as the protein's natural ligand, substrate, or cofactor. In kinases this is usually the ATP cleft, in nuclear receptors the ligand-binding domain, in epigenetic readers the acetyl-lysine pocket, and in enzymes the catalytic site. Because these pockets are structurally well defined and frequently supported by existing inhibitor chemotypes, orthosteric sites remain the fastest route from a chemical starting point to a functional degrader.

What separates an orthosteric warhead from an ordinary inhibitor is not binding affinity alone. The molecule must hold the target long enough for ubiquitination to occur, present a solvent-exposed position where a linker can be attached without disturbing the anchoring interactions, and tolerate the geometric constraints imposed by the recruited E3 ligase inside the ternary complex.

  • Anchor first, then exit: the interactions that define pocket recognition are secured before any attachment point is chosen.
  • Affinity is necessary but not sufficient: moderate-affinity ligands can drive efficient degradation when ternary complex geometry and cooperativity are favorable.
  • Pocket conservation drives selectivity risk: orthosteric sites are often shared across protein families, so warhead design must anticipate degradation of close homologs.
Design Aspect Orthosteric Warhead
Binding site Natural ligand, substrate, or cofactor pocket
Starting chemotype Existing inhibitors, ATP mimetics, substrate analogs
Selectivity behavior Higher homology risk within the same protein family
Exit vector availability Usually a well-defined solvent-exposed edge
Typical target classes Kinases, nuclear receptors, epigenetic readers, proteases
Services

BOC Sciences Orthosteric Warhead Design Services for PROTAC Development

Our design work is organized by target class, because the pocket geometry, the conserved anchoring residues, and the available exit vectors differ substantially between kinases, nuclear receptors, epigenetic readers, and enzymes. Each program begins with a structural review of the pocket and ends with a warhead series that has been tested for both binding and degradation compatibility.

Gene Therapy

Kinase Orthosteric Warhead Design

Kinases offer the deepest reservoir of orthosteric starting points, and most kinase degraders are built from hinge-binding scaffolds. We redesign type I, type II, and DFG-out inhibitors into warhead modules through ligand design for target protein workflows that preserve the hinge interaction and relocate the linker exit to a solvent-exposed vector.

  • Hinge retention: the donor-acceptor pair that anchors the warhead is kept, while peripheral substituents are rebuilt for conjugation.
  • Pocket-class adaptation: type I, type II, and DFG-out binders require different exit geometry and different conformational assumptions.
  • Selectivity mapping: gatekeeper and hinge-region differences across the kinome are compared to anticipate homology-driven degradation.
Gene Therapy

Nuclear Receptor Ligand-Binding Domain Warhead Design

Nuclear receptor ligand-binding domains are large hydrophobic cavities whose behavior depends on helix 12 positioning. We design warheads that stabilize a defined domain conformation and expose a peripheral handle for linker installation, supported by co-crystallization when experimental geometry is required.

  • H12-aware design: scaffolds are selected for the receptor conformation they stabilize rather than for potency alone.
  • Surface consideration: coactivator-facing surfaces are assessed so that the warhead does not simply reproduce agonist behavior.
  • Peripheral exit vectors: attachment points are placed on solvent-facing substituents to keep the core hydrogen-bond network intact.
Gene Therapy

Bromodomain and Epigenetic Reader Warhead Design

Acetyl-lysine pockets are shallow and water-mediated, which makes exit vector placement more demanding than in deep catalytic clefts. Starting from our warhead library, we develop mimetic cores and rigidify them so that linker attachment does not collapse pocket occupancy.

  • Acetyl-lysine mimicry: mimetic cores reproduce the conserved asparagine and water-network contacts of the reader pocket.
  • Domain and family selectivity: bromodomain 1 versus bromodomain 2 preference, and cross-family reader profiling, guide substitution.
  • Shallow-pocket engineering: hydrophobic capping and rigidification compensate for limited buried surface.
Gene Therapy

Enzyme Active-Site and Protease Warhead Design

Proteases, deubiquitinases, phosphatases, and methyltransferases present deeper and more polar clefts where substrate mimicry becomes the dominant design logic. We build warheads from substrate-derived and inhibitor-derived scaffolds, then confirm that pocket engagement is retained after chemical modification using binding affinity measurement.

  • Catalytic cleft recognition: the S1 or substrate-recognition subsite is used as the primary anchoring element.
  • Inhibitor-to-binder conversion: reactive or potency-driving groups are replaced with neutral isosteres where sustained inhibition is undesirable.
  • Cofactor competition: nucleotide, metal, or acyl-donor dependence is mapped before a design route is fixed.
Gene Therapy

Resistance-Mutant Orthosteric Warhead Design

Gatekeeper substitutions, hinge mutations, and ligand-binding domain point mutations reshape the orthosteric pocket and can abolish binding of a wild-type-derived warhead. We compare wild-type and variant pockets computationally, using molecular dynamics simulation to judge whether an existing scaffold can be salvaged or must be replaced.

  • Variant-driven comparison: side-chain volume, hydrogen-bond loss, and cavity redistribution are evaluated residue by residue.
  • Warhead re-engineering: substituents are repositioned to recover contacts that the mutation removed.
  • Mutant-selective window: designs are screened for preferential engagement of the variant over the wild-type protein where selectivity is the program goal.
Gene Therapy

Non-Inhibitory Orthosteric Degrader Design

For several target classes, a degrader that also blocks catalytic activity carries pharmacological consequences the program does not want. We therefore design binding-competent but functionally silent warheads, and validate them against matched PROTAC diastereomer design (negative control) compounds so that degradation and inhibition can be interpreted separately.

  • Functional silencing: individual polar contacts or a steric element are removed so that occupancy no longer translates into activity blockade.
  • Paired controls: active, inactive, and ligase-dead analogs are designed together to isolate degradation-specific effects.
  • Decoupled readouts: binding, degradation, and functional output are measured in the same cellular context.
Design Strategies

Orthosteric Warhead Design by Chemical Scaffold and Binding Interaction Class

The chemical structure of an orthosteric warhead determines how it recognizes the target binding pocket and which molecular modifications can be introduced without disrupting target engagement. Different functional groups and molecular scaffolds support distinct interaction patterns, including hydrogen bonding, ionic interactions, aromatic stacking, hydrophobic packing, and metal coordination. BOC Sciences evaluates these features in the context of target-specific pocket geometry and the intended degrader architecture.

The following classification describes representative chemical and interaction-based design approaches. These categories are not mutually exclusive, and a single warhead may combine several interaction types. The final selection depends on the three-dimensional arrangement of target residues, local protonation states, water networks, and the chemical environment of the binding pocket.

Chemical Scaffold Class Representative Binding Interactions Key Design Considerations
Heteroaromatic and fused heterocyclic structures Hydrogen bonding, aromatic stacking, and hydrophobic contacts. Heteroatom orientation, scaffold geometry, and substituent accessibility.
Purine- and pyrimidine-based structures Hydrogen-bond recognition and nucleotide-pocket complementarity. Hinge or nucleotide recognition, pocket selectivity, and solvent-facing modifications.
Carboxylate- and acidic group-containing structures Salt bridges and hydrogen bonding with basic residues. Ionization, desolvation, and permeability-related properties.
Amine- and basic nitrogen-containing structures Electrostatic interactions with acidic residues and hydrogen bonding. pKa, charge distribution, and interaction specificity.
Amide-, urea-, and peptidomimetic structures Directional hydrogen-bond networks and backbone recognition. Conformational control, stereochemistry, and modification tolerance.
Aromatic and hydrophobic structures Pi-stacking, van der Waals contacts, and hydrophobic packing. Shape complementarity, selectivity, and solubility.
Metal-coordinating structures Coordination with catalytic metal ions in protein binding pockets. Coordination geometry, metal selectivity, and ligand stability.
Macrocyclic and peptide-based structures Multiple hydrogen bonds, electrostatic contacts, and extended surface recognition. Conformational preorganization, molecular flexibility, and cellular exposure.

Heteroaromatic and Fused Heterocyclic Warhead Design

Heteroaromatic rings and fused heterocyclic systems are widely used in target-binding ligands because their nitrogen, oxygen, and sulfur atoms provide opportunities for directional molecular recognition. Their rigid or partially rigid ring systems can also help maintain a defined binding conformation. Depending on the pocket, these scaffolds may interact with backbone atoms, polar side chains, or adjacent aromatic residues.

  • Hydrogen-bond positioning: Optimize heteroatom placement to complement donor and acceptor groups within the orthosteric pocket.
  • Aromatic interaction: Evaluate stacking and hydrophobic contacts with aromatic residues such as phenylalanine, tyrosine, and tryptophan.
  • Scaffold modification: Explore ring substitution and heteroatom replacement while preserving the core binding orientation.

Purine- and Pyrimidine-Based Warhead Design

Purine and pyrimidine scaffolds provide useful starting points for targeting nucleotide-binding proteins, particularly kinases and enzymes that recognize adenine-containing cofactors. Their heterocyclic ring systems can reproduce important hydrogen-bonding patterns within nucleotide-binding pockets. Structural optimization focuses on maintaining the required recognition geometry while introducing chemical handles for degrader construction.

  • Nucleotide-pocket mimicry: Evaluate hydrogen-bond donor and acceptor arrangements that reproduce relevant nucleotide recognition patterns.
  • Substituent exploration: Modify peripheral positions to improve pocket complementarity and identify potential linker attachment sites.
  • Selectivity optimization: Investigate variable residues around conserved nucleotide-binding regions to distinguish related targets.

Carboxylate- and Acidic Group-Containing Warhead Design

Carboxylate, phosphonate, and other acidic functional groups can contribute to orthosteric recognition through ionic interactions and hydrogen bonding. Their negatively charged forms may establish favorable contacts with basic amino acid residues, particularly lysine and arginine, when the local electrostatic environment is suitable. These groups can also participate in metal-associated interactions in selected enzyme pockets.

  • Electrostatic complementarity: Evaluate interactions with positively charged residues and neighboring polar groups.
  • Ionization control: Assess pKa and protonation behavior to understand binding and physicochemical consequences.
  • Desolvation assessment: Balance favorable ionic recognition with the energetic cost of removing solvent molecules during binding.

Amine- and Basic Nitrogen-Containing Warhead Design

Amines, amidines, guanidines, and nitrogen-containing heterocycles can provide positively charged or hydrogen-bonding centers for orthosteric ligand recognition. When appropriately positioned, protonated nitrogen groups may form salt bridges with acidic residues such as aspartate and glutamate. Their contribution depends on local pH, pKa, solvent exposure, and the three-dimensional arrangement of surrounding functional groups.

  • Basic residue complementarity: Characterize potential salt bridges and hydrogen-bond interactions with acidic pocket residues.
  • Charge optimization: Adjust nitrogen substitution and basicity to balance binding strength and molecular properties.
  • Structural accessibility: Identify nitrogen-containing positions that can be modified without disrupting key interactions.

Amide-, Urea-, and Peptidomimetic Warhead Design

Amide, urea, and peptidomimetic structures offer multiple hydrogen-bond donor and acceptor sites that can reproduce the recognition features of natural substrates. These chemical motifs are particularly relevant for enzyme and protease targets with defined substrate-binding regions. Their directional interactions can support strong molecular recognition, although excessive flexibility or exposed polar groups may affect the properties of the complete degrader.

  • Hydrogen-bond network design: Optimize donor and acceptor arrangements with serine, threonine, asparagine, glutamine, and protein backbone atoms.
  • Conformational optimization: Evaluate stereochemistry and backbone constraints to maintain favorable binding conformations.
  • Peptidomimetic modification: Replace selected peptide bonds or side-chain groups to improve structural stability and chemical modification flexibility.

Aromatic and Hydrophobic Warhead Design

Aromatic and hydrophobic groups contribute to ligand recognition through pi-stacking, edge-to-face aromatic interactions, van der Waals contacts, and hydrophobic packing. These interactions are especially important in binding pockets containing aromatic or nonpolar residues. Their contribution must be balanced against molecular solubility and nonspecific hydrophobic association, particularly when an additional linker and E3 ligase recruiter increase the overall molecular size.

  • Aromatic recognition: Evaluate interactions with phenylalanine, tyrosine, and tryptophan residues.
  • Hydrophobic pocket complementarity: Optimize contact patterns with leucine, isoleucine, valine, and methionine residues.
  • Property balance: Adjust aromatic ring number, substitution, and lipophilicity to avoid unnecessary hydrophobic burden.

Metal-Coordinating Warhead Design

Some enzyme targets contain catalytic metal ions within their orthosteric active sites. Warheads incorporating hydroxamic acid, carboxylate, or nitrogen-containing donor groups may coordinate these metal centers and establish additional binding interactions. The surrounding protein residues, including histidine, aspartate, and glutamate, can contribute to metal positioning and the geometry of the coordination environment.

  • Coordination geometry: Assess the number and spatial arrangement of donor atoms required for metal recognition.
  • Active-site compatibility: Analyze the relationship between the metal center, catalytic residues, and surrounding ligand-binding regions.
  • Selective coordination: Evaluate metal preference and the potential for nonspecific interactions with other metal-containing proteins.

Macrocyclic and Peptide-Based Warhead Design

Macrocyclic and peptide-based ligands can recognize extended protein surfaces through multiple simultaneous interactions. Their larger contact areas may provide opportunities to target substrate-binding regions that are difficult to address with conventional compact heterocyclic molecules. Macrocyclization can also restrict conformational freedom and help maintain a favorable binding geometry.

  • Multi-point recognition: Evaluate combined hydrogen-bond, electrostatic, and hydrophobic interactions across extended binding surfaces.
  • Conformational preorganization: Investigate ring size, stereochemistry, and backbone constraints to stabilize target-compatible conformations.
  • Degrader integration: Assess linker attachment feasibility and the physicochemical impact of incorporating larger ligand structures into a degrader.
Workflow

Our Orthosteric Warhead Design Workflow for Targeted Protein Degraders

Design decisions are made in a fixed sequence so that structural evidence always precedes chemical commitment. Each stage produces a defined deliverable, and the program can stop or redirect at any point.

01

Project Consultation and Design Requirement Assessment

We review the target biology, the intended degradation outcome, the E3 ligase pairing, existing ligand data, and any prior degradation results to define what the warhead actually has to achieve.

  • Target class, disease relevance, and expression context
  • Available chemotypes, structures, and activity data
  • Preferred E3 ligase system and attachment strategy
02

Target Protein Binding Pocket Analysis

The orthosteric pocket is mapped for volume, polarity, conserved residues, and solvent exposure, and candidate exit vectors are prioritized before any molecule is drawn. This work is delivered through target structural analysis for TPD development.

  • Pocket druggability and subpocket decomposition
  • Conformational flexibility and cryptic subpocket detection
  • Exit vector ranking by solvent exposure and steric tolerance
03

Screening and Identification of Initial Target Protein Ligands

Candidate binders are assembled from known inhibitor classes, internal libraries, and structure-based generation, then prioritized by predicted pocket fit and synthetic accessibility using molecular docking for protein-ligand analysis.

  • Scaffold mining across related target families
  • Docking and interaction fingerprint scoring
  • Shortlist selection by tractability and novelty
04

Orthosteric Warhead Design and Structure Optimization

Shortlisted scaffolds are converted into warhead series with defined attachment points, then optimized iteratively for binding retention, exit vector accessibility, and compatibility with ternary complex formation.

  • Exit vector installation and linker-ready intermediates
  • Affinity and selectivity iteration across analogs
  • Degradation-compatible analog selection and reporting

Turn a Binding Scaffold into a Degradation-Ready Warhead

Partner with BOC Sciences to connect pocket analysis, scaffold selection, and exit vector design in one continuous program.

Start Your Warhead Project

Applications

Applications of Orthosteric Warhead Design in PROTAC Research

Warhead Modules for PROTAC Degraders

Orthosteric warheads supply the target-recognition half of a bifunctional molecule. We deliver them as linker-ready modules that slot directly into PROTAC design services, with attachment points already validated for geometry before in vitro degradation testing begins.

Warhead Design for Molecular Glue Degraders

Molecular glues often act at or near orthosteric surfaces where a small structural change converts an ordinary ligand into an interface stabilizer. Our warhead work feeds directly into molecular glue technology development.

Expanding the Range of Degradable Targets

Targets without catalytic activity can still be degraded if a ligand can be placed into a defined pocket or surface groove. Orthosteric and orthosteric-adjacent warheads extend degradable target space beyond classical enzyme active sites.

Overcoming Resistance Mutations

Because degradation removes the protein rather than blocking one function, warheads redesigned for mutated pockets can restore activity in models where the original inhibitor scaffold no longer engages the target.

Why Us

Why Choose BOC Sciences for Orthosteric Warhead Design?

 Integrated Computational and Experimental Capabilities

Structural analysis, docking, dynamics, and in vitro biophysical measurement sit inside one team, so a design hypothesis can be tested without handing the project between vendors. Binding results feed back into the next design round directly.

 Structure-Guided Medicinal Chemistry Strategies

Every substitution is tied to a structural rationale: which contact is being gained, which is being preserved, and which exit vector is being opened. This keeps series progression deliberate rather than empirical.

 Target-Specific Design and Flexible Optimization

Kinase, nuclear receptor, reader, and enzyme pockets are not treated with one template. Design rules, assay formats, and optimization priorities are set per target class and adjusted as data arrive.

 Seamless Connection to Linker Design and PROTAC Evaluation

Warheads leave our pipeline ready for conjugation, with recommended attachment chemistry and downstream testing already planned, including linker design and optimization services and degradation assessment.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

An orthosteric warhead is suitable for PROTAC design when it recognizes the target protein's natural ligand- or substrate-binding pocket and can retain that recognition after chemical modification. Binding affinity is important, but it is not the only selection criterion. The ligand should have a well-supported binding pose, preserve key residue interactions after linker attachment, and offer an accessible exit vector that can orient the linker toward a productive E3 ligase-target arrangement. Selectivity, solubility, permeability, and the behavior of the complete degrader should also be considered. Therefore, suitability is best judged through integrated binding, ternary complex, and degradation data.

Yes. Established inhibitors can be useful starting points because their target-binding modes and structure-activity relationships may already be understood. However, an inhibitor is not automatically a suitable warhead. The proposed linker attachment may disrupt hydrogen bonds, hydrophobic contacts, or other interactions that stabilize the ligand in the orthosteric pocket. Researchers should identify solvent-exposed positions, prepare linker-bearing analogs, and compare their target engagement with the parent ligand. They should then evaluate the complete degrader, since preserved binary affinity alone does not guarantee productive ternary complex formation or efficient protein degradation. This assessment helps determine whether an inhibitor scaffold can be repurposed or requires redesign.

Yes. A degrader warhead does not always need to inhibit the target's biochemical function. Its essential role is to bind the protein of interest and support formation of a productive complex with the recruited E3 ligase. A functionally silent or weakly inhibitory orthosteric ligand may therefore be useful if it provides adequate target engagement, tolerates linker modification, and enables favorable ternary complex geometry. The effect of orthosteric occupancy on endogenous ligand binding and target function should still be characterized. Ultimately, the full degrader must be tested for target degradation, because ligand binding by itself does not establish degradation activity.

BOC Sciences can begin with a review of the target protein, orthosteric pocket, available structures, known ligands, and project objectives. Structural analysis can map key residues, pocket shape, hydrogen-bond donors and acceptors, hydrophobic regions, and possible solvent-exposed modification positions. Candidate ligands can then be identified from known target binders or prioritized through virtual screening and molecular docking. For projects involving resistance-associated variants, wild-type and mutant pocket features can be compared. This workflow helps generate a ranked set of starting points for subsequent chemical optimization and experimental binding evaluation.

BOC Sciences' orthosteric warhead support can include target binding pocket analysis, ligand identification and screening, molecular docking, scaffold selection, structure-guided modification, and binding affinity evaluation. For PROTAC-oriented projects, we can also assess potential linker attachment positions and connect warhead optimization with ternary complex and degradation evaluation. The work can be scoped around an established inhibitor, a new orthosteric pocket, a resistance-associated mutant, or a non-inhibitory binder. The exact combination of methods depends on available target structures, ligand information, compounds, and the project's research objectives.

* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.

  • Verification code
Inquiry Basket